Page last updated: 2024-10-24

cacodylic acid and Carcinoma, Transitional Cell

cacodylic acid has been researched along with Carcinoma, Transitional Cell in 5 studies

dimethylarsinic acid : The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
" We hypothesize that arsenic methylation ability, defined as the ratios of monomethylarsonic acid (MMA(V))/inorganic arsenic (primary arsenic methylation index, PMI) and dimethylarsinic acid (DMA(V))/ MMA(V) (secondary arsenic methylation index, SMI), may modify the association between cumulative arsenic exposure (CAE, mg/L-year) and the risk of bladder cancer."7.72Arsenic methylation and bladder cancer risk in Taiwan. ( Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ, 2003)
" We hypothesize that arsenic methylation ability, defined as the ratios of monomethylarsonic acid (MMA(V))/inorganic arsenic (primary arsenic methylation index, PMI) and dimethylarsinic acid (DMA(V))/ MMA(V) (secondary arsenic methylation index, SMI), may modify the association between cumulative arsenic exposure (CAE, mg/L-year) and the risk of bladder cancer."3.72Arsenic methylation and bladder cancer risk in Taiwan. ( Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ, 2003)
"From weeks 97 to 104, urinary bladder tumors were observed in 12 of 31, eight of 31 and none of 33 in groups 1-3, respectively."1.30Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. ( Fukushima, S; Li, W; Wanibuchi, H; Wei, M; Yamamoto, S, 1999)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Sathua, K1
Srivastava, S1
Flora, SJS1
Chung, CJ1
Pu, YS1
Su, CT1
Chen, HW1
Huang, YK2
Shiue, HS1
Hsueh, YM3
Chen, YC1
Su, HJ1
Guo, YL1
Smith, TJ1
Ryan, LM1
Lee, MS1
Christiani, DC1
Huang, YL1
Yang, MH1
Wu, MM1
Chen, SY1
Hsu, LI1
Chen, CJ1
Wei, M1
Wanibuchi, H1
Yamamoto, S1
Li, W1
Fukushima, S1

Other Studies

5 other studies available for cacodylic acid and Carcinoma, Transitional Cell

ArticleYear
MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 128

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Arsenites; Cacodylic Acid; Carcinoma,

2020
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
    Cancer causes & control : CCC, 2010, Volume: 21, Issue:10

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Arsenic; Cacodylic Acid; Carcinoma,

2010
Arsenic methylation and bladder cancer risk in Taiwan.
    Cancer causes & control : CCC, 2003, Volume: 14, Issue:4

    Topics: Aged; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans

2003
Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
    Cancer causes & control : CCC, 2008, Volume: 19, Issue:8

    Topics: Adult; Aged; Arsenic; Arsenic Poisoning; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; C

2008
Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats.
    Carcinogenesis, 1999, Volume: 20, Issue:9

    Topics: Administration, Oral; Animals; Cacodylic Acid; Carcinogenicity Tests; Carcinoma, Transitional Cell;

1999